Profile
PSTV VRTX REGN SGEN ALNY ARGX
Company Name Plus Therapeutics, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $6.12M $116.96B $55.30B $43.15B $41.50B $33.66B
Employees 0.02K 6.10K 15.16K 3.26K 2.23K 1.60K
CEO Dr. Marc H. Hedrick M.B.A., M.D. Dr. Reshma Kewalramani FASN, M.D. Leonard S. Schleifer David R. Epstein Yvonne L. Greenstreet Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
PSTV VRTX REGN SGEN ALNY ARGX
Quant Rating Score 2 2 4 3 1 1
Quant Rating Sell Sell Buy Neutral Strong Sell Strong Sell
Trading
PSTV VRTX REGN SGEN ALNY ARGX
Last Close $0.3478 $445.2 $525 $228.74 $326.09 $551.22
High 52 $1.9 $516.74 $1201.76 $228.74 $326.09 $671.75
Low 52 $0.18 $396.64 $482.92 $228.74 $224.58 $434.22
Price vs. 52 Week High -81.69 % -13.84 % -56.31 % 0 % 0 % -17.94 %
Price vs. 52 Week Low 93.22 % 12.24 % 8.71 % 0 % 45.2 % 26.94 %
Total Return
PSTV VRTX REGN SGEN ALNY ARGX
1 Month Return 21.23 % 0.71 % 7.08 % 0 % 7.07 % -3.84 %
3 Month Return -65.9 % -8.16 % -14.91 % 0 % 27.4 % -2.78 %
6 Month Return -69.76 % 10.55 % -26.3 % 0 % 38.58 % -10.37 %
9 Month Return -73.45 % -5.23 % -49.85 % 0 % 18.12 % 0.72 %
YTD Return -69.76 % 10.55 % -26.3 % 0 % 38.58 % -10.37 %
1 Year Return -76.81 % -5.53 % -50.33 % 0 % 34.02 % 26.94 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
PSTV VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.34 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -18.67 % -3.53 % 3.85 % -5.87 % -1.49 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
PSTV VRTX REGN SGEN ALNY ARGX
Asset Growth -41.75 % -0.87 % 36.55 %
Gross Profit Growth 100 % 10.25 % 77.08 %
Revenue Growth -100 % 11.66 % 78.6 %
Revenue 3 Year - 45.6 % 275.84 %
Revenue 5 Year -100 % 163.93 % 1701.04 %
Revenue 10 Year -100 % 1632.15 % 5950.81 %
EBIT Growth 30.53 % -93.69 % 128.87 %
Net Income Growth 2.54 % -114.8 % 382.34 %
Net Income 3 Yeari Growth Per Share 98.83 % -122.89 % 274.39 %
Net Income 5 Yeari Growth Per Share 99.83 % -145.38 % 396.61 %
Net Income 10 Yeari Growth Per Share 57.72 % 33.84 % 938.02 %
Operating Income Growth -10.31 % -106.08 % 94.91 %
Operating Cash Flow Growth (CFG) 17.87 % -113.93 % 80.31 %
Operating 3 Year CFG 98.76 % -118.65 % 88.36 %
Operating 5 Year CFG 99.75 % -131.3 % -135.21 %
Operating 10 Year CFG 57.64 % 12.43 % -64 %
EPS Growth 95.28 % -114.8 % 369.77 %
EPS Diluted Growth 60.14 % -114.97 % 347.67 %
Book Value Per Share 68.6 % -6.59 % 28.16 %
Share Holder 3 Year Equity Growth Per Share -101 % 62.6 % 85.14 %
Share Holder 5 Year Equity Growth Per Share -101.07 % 168.85 % 200.53 %
Share Holder 10 Year Equity Growth Per Share -91.05 % 1265.7 % 1039.11 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth -19.47 % 116.42 % 95.27 %
Free Cash Flow Growth 13.57 % -124.1 % 67.46 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
PSTV VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM -116.81 % 86.03 % 84.94 % 79.1 % 86.01 % 46.33 %
Return on Assets TTM -224.93 % -4.32 % 11.98 % -16.61 % -6.4 % 13.45 %
Return on Equity TTM 238.98 % -6.25 % 14.77 % -20.8 % -509.33 % 16.83 %
Return on Capital Employed TTM -997.46 % -3.89 % 11.35 % -21.46 % -3.68 % -0.5 %
Net Income Per EBT TTM 100 % 329.41 % 90.27 % 101.33 % 75.89 % 25990.14 %
EBT Per Ebit TTM 181.61 % 40.44 % 129.3 % 98.26 % 308.03 % -11.64 %
EBIT Per Revenue TTM -1167.47 % -6.69 % 27.37 % -31.24 % -4.91 % -1.24 %
Cash Flow To Debt Ratio TTM -30532.5 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Receivables Turnover TTM - 6.15 2.53 3.91 5.62 2.36
Payables Turnover TTM - 3.49 3.01 1.97 3.37 2.39
Inventory Turnover TTM - 1.14 0.66 0.96 5.01 2.93
Fixed Asset Turnover TTM 353.31 % 421.34 % 300.07 % 665.41 % 337.41 % 5106.8 %
Asset Turnover TTM 10.61 % 48.51 % 37.52 % 53.41 % 55.72 % 35.83 %
Operating Cash Flow Per Share TTM -1.65 -3.82 37.05 -2.46 -0.35 -1.07
Free Cash Flow Per Share TTM -1.74 -4.9 28.3 -2.88 -0.58 -1.09
Cash Per Share TTM 133.21 % 2413.86 % 7825.12 % 939.52 % 2024.29 % 4688.94 %
Operating Cash Flow Sales Ratio TTM -954.89 % -8.83 % 28.06 % -23.12 % -1.92 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 105.35 % 128.33 % 76.4 % 117.04 % 167.11 % 102.26 %
Cash Flow Coverage Ratios TTM -30532.5 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Price To Free Cash Flows Ratio TTM -0.48 -92.97 18.31 -81.26 -550.45 -433.65
Price To Operating Cash Flows Ratio TTM -0.11 -119.36 14.06 -93.1 -914.84 -515.25
Price Cash Flow Ratio TTM -0.11 -119.36 14.06 -93.1 -914.84 -515.25
Income Statement (TTM)
PSTV VRTX REGN SGEN ALNY ARGX
Revenue $0.01B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $0B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 0% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0.01B $0.49B $5.32B $-0.62B $-0.18B $0.11B
Net Income $-0.01B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -2.34 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
PSTV VRTX REGN SGEN ALNY ARGX
Long Term Debt $0B $1.66B $1.98B $0.04B $0B $0.03B
Total Liabilities $0.02B $6.12B $8.41B $0.87B $4.17B $0.7B
Total Equity $-0.01B $16.41B $29.35B $2.8B $0.07B $5.5B
Total Investments $0B $6.65B $15.42B $1.42B $1.73B $1.93B
Total Debt $0B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0.01B $22.53B $37.76B $3.67B $4.3B $6.2B
Cash Flow Statement (TTM)
PSTV VRTX REGN SGEN ALNY ARGX
Net Income $-0.01B $-0.54B $4.41B $-0.61B $-0.28B $-0.02B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.08B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 39.375
AARD Aardvark Therapeutics, Inc. Common Stock 13.52
ABCL AbCellera Biologics Inc. 3.43
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.68
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.16
ABPWW 0.0207
ABSI Absci Corporation 2.57
ABUS Arbutus Biopharma Corporation 3.09
ABVC ABVC BioPharma, Inc. 2.225
ABVX Abivax SA American Depositary Shares 7.65
ACAD ACADIA Pharmaceuticals Inc. 21.57
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.61
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.26
ACIU AC Immune SA 2.03
ETFs With Exposure to PSTV
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 303.93
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 135.04
VXF Vanguard Extended Market Index Fund 0 192.71
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 146.26
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 146.27
VEMPX Vanguard Extended Market Index InstlPlus 0 360.93
Unlock